Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nymox Pharmaceutical Corporation - Common Stock
(NQ:
NYMX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nymox Pharmaceutical Corporation - Common Stock
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
July 25, 2023
NYMOZARFEX 15 mg Minimal Treatment of Low Grade Prostate Cancer Leads to Significant Long-Term Reduction in Incidence of Associated Prostate Cancer Surgery and Radiotherapy
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports on U.S. Patent Issuances
July 18, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Update
July 13, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
July 12, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Update
July 07, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Delisting from NASDAQ
July 05, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Provides Current Update
May 10, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Provides Corporate Update
April 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
March 21, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Officially Granted Extension to Regain Listing Requirements
March 15, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review
February 15, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Appeals Deficiency Letter
January 06, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPH
December 05, 2022
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
May 2023 Market Cap Requirement Update
November 25, 2022
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today